Frost & Sullivan awards AKI Product Leadership Award to BioPortoRead more
BioPorto launches the first human NGAL monomer specific assay.Read more
American Association for Clinical Chemistry (AACC) push for AKI biomarkers including NGAL in new cover storyRead more
We are happy to announce that The NGAL Test™ application notes are now available for the Siemens Dimension Vista® Integrated Chemistry System's nephelometric chanel and the turbidemetric analyzer from Beckman Coulter UniCel® DxC 800 Synchron® Clinical System. Both application notes are designed for urine samples only.Read more
The Focus meeting 2013 in York is one of the most important clinical science events in the United Kingdom (UK). Arranged by the association of clinical chemistry in the UK, the meeting attracts participants from all major UK healthcare laboratories and many university departments.Read more
Ever since NGAL as a diagnostic biomarker was linked to AKI, NGAL has been given a central role in many international AKI initiatives.
The connection between NGAL and AKI diagnostics has led to a wealth of forums and informational resources strengthening the focus on the subject.
To provide an overview and easy access to all these free available resources, we have collected the most recent high impact links and posted them on www.NGAL.comRead more
Senior Consultant and NGAL expert Dr. Wolfgang Huber from The Technische Universität München will give a lecture about NGAL and its application for diagnosis and management of acute kidney injury.Read more
This is the question asked in a journalistic
article recently published by College of American
The journalist has interviewed a handful of the worlds leading kidney researchers about their outlook on a future where earlier diagnosis and management of acute kidney injury is possible. The article gives an excellent review and status update on NGAL.
Please read the article here -Read more
Dako Denmark A/S, Reagent Partnership Division, presented data and results of a validation study on The NGAL Test™ at the21st International Congress of Clinical Chemistry and Laboratory Medicine (IFCC-World Lab) in Berlin.Read more
BioPorto has CE-marked and is now launching The NGAL Test™ for diagnostic use in Europe.Read more
BioPorto Diagnostics is proud to announce a scientific poster presentation at the BRS/RA Conference in Manchester that includes data obtained with The NGAL Test...Read more
BioPorto Diagnostics announces the presentation of a new scientific study that includes data obtained with The NGAL Test - the company's forthcoming diagnostic test for acute kidney injury...Read more